Prostate cancer

Objetivo educativo: Gain insight on the appropriate treatment of BCR in post-RP men, considering the importance of risk factors, PSA levels, and the role of ADT

Especialidad: Urology, radiation oncology, (medical oncology)

Público destinatario: CME (basic), Residents (senior)

Última actualización: May 2021

Antecedentes:

Biochemical recurrence (BCR) occurs in a significant proportion of patients who received primary curative treatment for localised PCa. Because not all patients with PSA-only recurrence after RP will develop clinical recurrences, a careful balance must be made in aiming for a delay in the onset of metastatic disease and death, while avoiding overtreatment of patients whose disease may never affect their overall survival or quality of life. Multiple clinical factors must be taken into account to optimally treat a patient with N0 M0 PSA-recurrent PCa.